search
Back to results

Fertility Preservation in Cases of Klinefelter Syndrome. (FERTIPRESERVE)

Primary Purpose

Klinefelter Syndrome

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Seminal analyses and testicular biopsy
Sponsored by
Hospices Civils de Lyon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Klinefelter Syndrome focused on measuring Klinefelter Syndrome, Azoospermia, Seminal analyses, Testicular biopsy

Eligibility Criteria

15 Years - 55 Years (Child, Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Klinefelter Syndrome with 47,XXY non-mosaic
  • Androgenotherapy stopped since more than 6 months

Exclusion Criteria:

  • Antecedent of Radiotherapy or chemotherapy
  • Psychological trouble
  • Treatment interfering with spermatogenesis
  • Androgenotherapy non stopped

Sites / Locations

  • Service de Biologie de la Reproduction - CECOS - Groupe Hospitalier Pellegrin
  • Service d'Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie Est, Hospices Civils de Lyon
  • Service de Biologie de la Reproduction - Hôpital de la Conception
  • Groupe de Médecine de la Reproduction - CECOS Midi-Pyrénées - Hôpital Paule de Viguier)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Young group

Adult group

Arm Description

Patient aged 15-22 years for seminal analyses and testicular biopsy

Patient aged 23-55 years for seminal analyses and testicular biopsy

Outcomes

Primary Outcome Measures

TEsticular Sperm Extraction (TESE)
Improvement of sperm retrieval rate by Testicular Sperm extraction (TESE) in the "Young" group compare to "Adult" group.

Secondary Outcome Measures

Androgenotherapy
Influence of antecedent of androgenotherapy before Testicular Sperm extraction (TESE) : treatment or not, duration of treatment
Prognosis factors
Identification of prognosis factors of sperm retrieval (by TESE) in the two groups "Young" and "Adult"
Histopathologist analyses
Histopathologist analyses of testicular biopsy in the two groups "Young" and "Adult". In the 2 groups, comparison of cases with and without sperm.

Full Information

First Posted
August 6, 2013
Last Updated
January 9, 2020
Sponsor
Hospices Civils de Lyon
search

1. Study Identification

Unique Protocol Identification Number
NCT01918280
Brief Title
Fertility Preservation in Cases of Klinefelter Syndrome.
Acronym
FERTIPRESERVE
Official Title
Fertility Preservation in Cases of Spermatogenesis Failure : Prospective Study for Klinefelter Syndrome With Non-mosaic Karyotype (47, XXY, Homogeneous)
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Completed
Study Start Date
September 20, 2010 (Actual)
Primary Completion Date
September 17, 2018 (Actual)
Study Completion Date
September 17, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Klinefelter Syndrome (KS) is the most common sex chromosomal abnormalities (1/600 newborn males), and is characterized by a hypergonadism hypogonadism. Until few years ago, mostly non-mosaic KS was considered as a model of a complete male infertility although few KS (4-8%) have an oligospermia. Recent studies in adult with non-mosaic KS reported the possibility of sperm retrieval by testicular biopsy (TESE) in around 50% cases and more than some pregnancies have been obtained after TESE with Intracytoplasmic Sperm Injection (ICSI). Since 1997, more than one hundred births are described. As some studies shown a decrease of successful sperm retrieval with the increasing of age, we plan to compare the potential of sperm retrieval between two groups "adult" (23-55 years) and "young" after the onset of puberty (15-22 years). The study will be performed by searching spermatozoa on two seminal analyses spaced out 3 months followed by a testicular biopsy if the azoospermia is confirmed on semen analyses.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Klinefelter Syndrome
Keywords
Klinefelter Syndrome, Azoospermia, Seminal analyses, Testicular biopsy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
141 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Young group
Arm Type
Experimental
Arm Description
Patient aged 15-22 years for seminal analyses and testicular biopsy
Arm Title
Adult group
Arm Type
Other
Arm Description
Patient aged 23-55 years for seminal analyses and testicular biopsy
Intervention Type
Procedure
Intervention Name(s)
Seminal analyses and testicular biopsy
Intervention Description
Two seminal analyses spaced out 3 months followed by a testicular biopsy if the azoospermia is confirmed on semen analyses.
Primary Outcome Measure Information:
Title
TEsticular Sperm Extraction (TESE)
Description
Improvement of sperm retrieval rate by Testicular Sperm extraction (TESE) in the "Young" group compare to "Adult" group.
Time Frame
15 months
Secondary Outcome Measure Information:
Title
Androgenotherapy
Description
Influence of antecedent of androgenotherapy before Testicular Sperm extraction (TESE) : treatment or not, duration of treatment
Time Frame
15 months
Title
Prognosis factors
Description
Identification of prognosis factors of sperm retrieval (by TESE) in the two groups "Young" and "Adult"
Time Frame
15 months
Title
Histopathologist analyses
Description
Histopathologist analyses of testicular biopsy in the two groups "Young" and "Adult". In the 2 groups, comparison of cases with and without sperm.
Time Frame
15 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Klinefelter Syndrome with 47,XXY non-mosaic Androgenotherapy stopped since more than 6 months Exclusion Criteria: Antecedent of Radiotherapy or chemotherapy Psychological trouble Treatment interfering with spermatogenesis Androgenotherapy non stopped
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ingrid PLOTTON, MD
Organizational Affiliation
Hospices Civils de Lyon
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service de Biologie de la Reproduction - CECOS - Groupe Hospitalier Pellegrin
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Facility Name
Service d'Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie Est, Hospices Civils de Lyon
City
Bron
ZIP/Postal Code
69677
Country
France
Facility Name
Service de Biologie de la Reproduction - Hôpital de la Conception
City
Marseille
ZIP/Postal Code
13385
Country
France
Facility Name
Groupe de Médecine de la Reproduction - CECOS Midi-Pyrénées - Hôpital Paule de Viguier)
City
Toulouse
ZIP/Postal Code
31059
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
36112034
Citation
Renault L, Labrune E, Giscard d'Estaing S, Cuzin B, Lapoirie M, Benchaib M, Lornage J, Soignon G, de Souza A, Dijoud F, Fraison E, Pral-Chatillon L, Bordes A, Sanlaville D, Schluth-Bolard C, Salle B, Ecochard R, Lejeune H, Plotton I. Delaying testicular sperm extraction in 47,XXY Klinefelter patients does not impair the sperm retrieval rate, and AMH levels are higher when TESE is positive. Hum Reprod. 2022 Oct 31;37(11):2518-2531. doi: 10.1093/humrep/deac203.
Results Reference
derived
PubMed Identifier
25423570
Citation
Plotton I, Giscard d'Estaing S, Cuzin B, Brosse A, Benchaib M, Lornage J, Ecochard R, Dijoud F, Lejeune H; FERTIPRESERVE group. Preliminary results of a prospective study of testicular sperm extraction in young versus adult patients with nonmosaic 47,XXY Klinefelter syndrome. J Clin Endocrinol Metab. 2015 Mar;100(3):961-7. doi: 10.1210/jc.2014-3083. Epub 2014 Nov 25.
Results Reference
derived

Learn more about this trial

Fertility Preservation in Cases of Klinefelter Syndrome.

We'll reach out to this number within 24 hrs